share_log

6-K: AstraZeneca Strengthens Its Cardiovascular Pipeline with Agreement for a Pre-Clinical Novel Lipid-Lowering Therapy

6-K: AstraZeneca Strengthens Its Cardiovascular Pipeline with Agreement for a Pre-Clinical Novel Lipid-Lowering Therapy

6-K:阿斯利康通过达成临床前新型降脂疗法协议,加强了其心血管产品线
美股SEC公告 ·  10/07 06:43
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息